CAS 1358715-18-0

Codes: Fluzoparib

Application context (from source-drug indications)

Breast cancerFluzoparibPeritoneal cancerFluzoparibOvarian cancerFluzoparibFallopian tube cancerFluzoparibProstate cancerFluzoparib三阴性乳腺癌Fluzoparib

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Fluzoparib	Tier C — Watch / trade	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

FluzoparibOriginator routesteps: 1total yield: 205 mg (Fluzoparib)

2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid→2-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyrazine→Fluzoparib

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.